Long-term outcome after liver transplantation in Egyptians transplanted for hepatitis C virus cirrhosis

2003 ◽  
Vol 35 (7) ◽  
pp. 2777-2778
Author(s):  
H Khalaf
Keyword(s):  
Liver Transplantation ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Term Outcome ◽  
Long Term Outcome

Long-term outcome of hepatitis C virus infection after liver transplantation

1997 ◽  
Vol 7 (2) ◽  
pp. 143-144
Author(s):  
K BOKER ◽  
G DALLEY ◽  
M BAHR ◽  
H MASCHEK ◽  
H TILLMANN ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Hepatitis C Virus Infection ◽  
Term Outcome ◽  
Long Term Outcome

Long-term outcome of hepatitis C virus infections acquired after pediatric liver transplantation

2011 ◽  
Vol 17 (12) ◽  
pp. 1474-1480 ◽  
Author(s):  
Carla Venturi ◽  
Javier Bueno ◽  
Lluís Castells ◽  
Jesus Quintero ◽  
Isabel Casas ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Pediatric Liver Transplantation ◽  
Virus Infections ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Pediatric Liver

scholarly journals Long-term outcome of hepatitis C virus infection after liver transplantation

Hepatology ◽  
1997 ◽  
Vol 25 (1) ◽  
pp. 203-210 ◽  
Author(s):  
K. H. Böker ◽  
G. Dalley ◽  
M. J. Bahr ◽  
H. Maschek ◽  
H. L. Tillmann ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Hepatitis C Virus Infection ◽  
Term Outcome ◽  
Long Term Outcome

Long-Term Outcome After Antiviral Therapy of Patients With Hepatitis C Virus Infection and Decompensated Cirrhosis

2011 ◽  
Vol 9 (3) ◽  
pp. 249-253 ◽  
Author(s):  
Angelo Iacobellis ◽  
Francesco Perri ◽  
Maria Rosa Valvano ◽  
Nazario Caruso ◽  
Grazia Anna Niro ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Antiviral Therapy ◽  
Decompensated Cirrhosis ◽  
Hepatitis C Virus Infection ◽  
Term Outcome ◽  
Long Term Outcome

P6406Platelet reactivity in Hepatitis C virus infected patients on dual antiplatelet therapy for acute coronary syndrome

2019 ◽  
Vol 40 (Supplement_1) ◽  
Author(s):  
F Scudiero ◽  
R Valenti ◽  
R Marcucci ◽  
G D Sanna ◽  
A M Gori ◽  
...  
Keyword(s):  
Acute Coronary Syndrome ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Platelet Reactivity ◽  
Multivariable Analysis ◽  
Hcv Infection ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Coronary Syndrome

Abstract Background Coronary artery disease (CAD) has been recognized as a serious and potentially life-threatening complication of Hepatitis C Virus (HCV) infection. High on treatment platelet reactivity has been associated with high risk of ischemic events in patients with CAD, but data regarding the association with HCV infection are still lacking. Purpose We sought to assess platelet reactivity on dual anti-platelet therapy and long-term outcome of acute coronary syndrome (ACS) patients infected with HCV. Methods ACS patients infected with HCV were matched to ACS patients without HCV for age, sex, diabetes, hypertension and renal function. Primary and secondary study endpoints were the proportion of patients with high on treatment platelet reactivity (HTPR) and long-term outcomes, respectively. Results HCV-infected ACS patients had higher levels of platelet reactivity (ADP10-LTA: 56% ± 18% vs. 44% ± 22%; p=0.002; Arachidonic Acid-LTA: 25% ± 21% vs. 16% ± 15%; p=0.011) and higher rate of HTPR on clopidogrel and aspirin compared with non-HCV patients. Multivariable analysis demonstrated HCV-infection to be an independent predictor of HTPR. At follow-up, estimated major adverse clinical events (MACE: cardiac death, non fatal myocardial infarction and any revascularization) were 57% vs. 37%, p=0.006 in HCV-infected ACS and non-HCV, respectively. Also, TIMI major bleeding rates were higher in HCV-infected subjects (11% vs. 3%; p=0.043) as compared with non-infected patients. Platelet function according to HCV status Conclusions ACS patients with HCV infection have increased on treatment platelet reactivity, higher rate of HTPR, MACE and bleedings as compared with non-HCV patients.

Sign in / Sign up

Export Citation Format

Share Document